Literature DB >> 26175398

Elevation of serum GGT and LDH levels, together with higher BCLC staging are associated with poor overall survival from hepatocellular carcinoma: a retrospective analysis.

Zongguo Yang1, Peiyan Ye2, Qingnian Xu1, Yunfei Lu1, Bozong Tang1, Qiang Wang1, Shishi Chen1, Xiaorong Chen1.   

Abstract

Serum biomarkers predicting prognosis have not been adequately explored in HCC patients. The aim of this study was to investigate prognostic significance of parameters of liver function, tumor markers, and other clinicopathological features in HCC patients. Medical records of HCC patients were retrospectively extracted and overall survival was evaluated with the Kaplan-Meier method. Significant difference was estimated with the Log rank method. Univariate and multivariate analyses were used for the study of significance of prognostic factor. A total of 273 HCC patients were included in this analysis. According to the Cox regression analysis and Kaplan-Meier event analysis, GGT and LDH levels of liver function tests were significantly associated with HCC overall survival. Elevated serum CEA level was a risk factor related to poor HCC overall survival. And advanced BCLC staging contributed to a lower overall survival in HCC patients. HCC could benefit from surgical resection, TACE, and radiotherapy. ROC curves demonstrated that different from CEA, elevated GGT and LDH could accurately predict HCC overall survival. In conclusion, serum GGT and LDH together with higher BCLC staging should be potential predictive factors for HCC overall survival.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26175398

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  13 in total

1.  Ductular reaction, cytokeratin 7 positivity, and gamma-glutamyl transferase in multistage hepatocarcinogenesis in rats.

Authors:  Andrea Janz Moreira; Graziella Ramos Rodrigues; Silvia Bona; Leila Xavier Sinigaglia Fratta; Giovana Regina Weber; Jaqueline Nascimento Picada; Jorge Luiz Dos Santos; Carlos Thadeu Cerski; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  Protoplasma       Date:  2016-08-15       Impact factor: 3.356

2.  Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy.

Authors:  Xiaopeng Yan; Xu Fu; Min Deng; Jun Chen; Jian He; Jiong Shi; Yudong Qiu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

3.  Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection.

Authors:  Wan-Li Wang; Xing-Long Zheng; Zhi-Yong Zhang; Ying Zhou; Jie Hao; Gang Tang; Ou Li; Jun-Xi Xiang; Zheng Wu; Bo Wang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

4.  Association Between Hepatocellular Carcinoma and Type 2 Diabetes Mellitus in Chinese Hepatitis B Virus Cirrhosis Patients: A Case-Control Study.

Authors:  Huixian Han; Han Deng; Tao Han; Haitao Zhao; Feifei Hou; Xingshun Qi
Journal:  Med Sci Monit       Date:  2017-07-09

5.  Independent risk factors for disease recurrence after surgery in patients with hepatitis B virus-related hepatocellular carcinoma ≤3 cm in diameter.

Authors:  Ling-Ling He; Xiao-Li Liu; Shuan Zhang; Meng-Ge Li; Xian-Bo Wang; Yu-Yong Jiang; Zhi-Yun Yang
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-03-30

Review 6.  Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New.

Authors:  Luca Faloppi; Maristella Bianconi; Riccardo Memeo; Andrea Casadei Gardini; Riccardo Giampieri; Alessandro Bittoni; Kalliopi Andrikou; Michela Del Prete; Stefano Cascinu; Mario Scartozzi
Journal:  Biomed Res Int       Date:  2016-05-29       Impact factor: 3.411

7.  Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization.

Authors:  Zongguo Yang; Jianliang Zhang; Yunfei Lu; Qingnian Xu; Bozong Tang; Qiang Wang; Wensi Zhang; Shishi Chen; Lingqing Lu; Xiaorong Chen
Journal:  Oncotarget       Date:  2015-12-15

8.  Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients.

Authors:  Noemi Pavo; Markus Raderer; Georg Goliasch; Raphael Wurm; Guido Strunk; Anna Cho; Johannes F Novak; Heinz Gisslinger; Günther G Steger; Michael Hejna; Wolfgang Köstler; Sabine Zöchbauer-Müller; Christine Marosi; Gabriela Kornek; Leo Auerbach; Sven Thorben Schneider; Bernhard Parschalk; Werner Scheithauer; Robert Pirker; Barbara Kiesewetter; Richard Pacher; Christoph Zielinski; Martin Hülsmann
Journal:  Oncotarget       Date:  2017-04-16

9.  Preoperative prediction of hepatocellular carcinoma with portal vein tumor thrombus based on conventional data.

Authors:  Pengpeng Zhu; Yan Liao; Jiyuan Fan; Xin Li; Lili Su; Jun Li; Shengguang Yuan; Junxiong Yu; Weijia Liao
Journal:  Oncotarget       Date:  2017-10-31

10.  A model combining TNM stage and tumor size shows utility in predicting recurrence among patients with hepatocellular carcinoma after resection.

Authors:  Yu Zhang; Shu-Wei Chen; Li-Li Liu; Xia Yang; Shao-Hang Cai; Jing-Ping Yun
Journal:  Cancer Manag Res       Date:  2018-09-20       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.